Ex parte THOMAS et al. - Page 10




          Appeal 97-1554                                                              
          Application 08/495,593                                                      

               B.   Discussion                                                        

                    1.   Prima facie obviousness                                      
               Applicants suggest in the Appeal Brief that the showings               
          in the specification and the Schwahn overcome any "possible"                
          prima facie case of obviousness made out by the prior art                   
          (page 2).      Not clear on this record is whether applicants               
          maintain that the examiner has failed to make out a prima                   
          facie case of obviousness.         Rule 192 [37 CFR § 1.92]                 
          requires an applicant to set out the reasons why a rejection                
          is not proper.  Accordingly, we consider only the reasons                   
          advanced by applicants in their appeal brief--not some other                
          arguments which we can imagine could have been made.                        
               The sole argument we have uncovered which arguably                     
          relates to prima facie obviousness appears on page 5 of the                 
          Appeal Brief.  There applicants contend that there is no hint               
          in Rath of the use of a polyisobutylamine manufactured by the               
          hydroformylation process of Kummer.  According to counsel for               
          applicants, at the time Rath filed a patent application (5                  
          August 1988 in Germany), the most common commercially                       
          available polyisobutyamines were manufactured via the chlorine              
          route.  Applicants reason that the reference in Rath to                     
                                       - 10 -                                         





Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007